» Articles » PMID: 35936811

Clinical, Laboratory and Bacterial Profile of Spontaneous Bacterial Peritonitis in Vietnamese Patients with Liver Cirrhosis

Overview
Journal Hepat Med
Publisher Dove Medical Press
Specialty Gastroenterology
Date 2022 Aug 8
PMID 35936811
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To determine several clinical and laboratory features as well as the bacterial profile of spontaneous bacterial peritonitis (SBP) in 58 Vietnamese patients admitted to a single center due to liver cirrhosis.

Methods: We retrospectively analyzed bacteriological, clinical and laboratory characteristics of patients with SBP admitted to the Gastroenterology and Hepatology Center from July 2019 to July 2020.

Results: Out of a total 58 SBP patients, 41 (70.9%) had culture-negative neutrocytic ascites. The majority of patients experienced abdominal pain (93,1%) and large ascites (65,5%). Gram-negative bacteria formed the main pathogens (14/17). (9/17) was the predominant cause followed by (2/17). Antibiotic sensitivity rate of for third generation cephalosporin was low but high for aminoglycoside and carbapenem antibiotics. The resistance of was significant against fluoroquinolones (100%). All 3 cases of gram-positive bacteria were sensitive to vancomycin.

Conclusion: Our study reported the bacteriological and clinical characteristics of patients with SBP and compared these findings between two groups: positive ascitic fluid culture and negative fluid culture. Ascitic fluid culture can guide for the right antibiotic choice since resistance to commonly prescribed antibiotics is common in SBP patients.

Citing Articles

Quadruple Complication in a Patient With Liver Cirrhosis: A Diagnostic Conundrum.

Kamath S, Kumar U, Sarkar N, Shrivastava V Cureus. 2024; 16(7):e64953.

PMID: 39161516 PMC: 11331002. DOI: 10.7759/cureus.64953.


Bacterial profile, drug resistance pattern, clinical and laboratory predictors of ascites infection in cirrhosis patients.

Helil A, Haile S, Birhanu Y, Desalegn H, Desalegn D, Geremew R BMC Infect Dis. 2024; 24(1):528.

PMID: 38797850 PMC: 11128108. DOI: 10.1186/s12879-024-09418-6.

References
1.
NAVARRO . Spontaneous Bacterial Peritonitis. Curr Treat Options Gastroenterol. 2000; 2(6):457-462. DOI: 10.1007/s11938-999-0049-7. View

2.
Pitout J, Laupland K . Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008; 8(3):159-66. DOI: 10.1016/S1473-3099(08)70041-0. View

3.
Angeloni S, Leboffe C, Parente A, Venditti M, Giordano A, Merli M . Efficacy of current guidelines for the treatment of spontaneous bacterial peritonitis in the clinical practice. World J Gastroenterol. 2008; 14(17):2757-62. PMC: 2709049. DOI: 10.3748/wjg.14.2757. View

4.
Alaniz C, Regal R . Spontaneous bacterial peritonitis: a review of treatment options. P T. 2009; 34(4):204-10. PMC: 2697093. View

5.
Gines P, Quintero E, Arroyo V, Teres J, Bruguera M, Rimola A . Compensated cirrhosis: natural history and prognostic factors. Hepatology. 1987; 7(1):122-8. DOI: 10.1002/hep.1840070124. View